Anúncio
Mercado fechado

  • BOVESPA

    119.662,38
    +94,85 (+0,08%)
     

  • MERVAL

    38.390,84
    +233,89 (+0,61%)
     

  • MXX

    52.222,94
    -52,71 (-0,10%)
     

  • PETROLEO CRU

    78,49
    -0,13 (-0,17%)
     

  • OURO

    2.348,40
    +30,40 (+1,31%)
     

  • Bitcoin USD

    66.584,52
    +373,39 (+0,56%)
     

  • CMC Crypto 200

    1.381,03
    -36,84 (-2,60%)
     

  • S&P500

    5.431,60
    -2,14 (-0,04%)
     

  • DOW JONES

    38.589,16
    -57,94 (-0,15%)
     

  • FTSE

    8.146,86
    -16,81 (-0,21%)
     

  • HANG SENG

    17.941,78
    -170,85 (-0,94%)
     

  • NIKKEI

    38.814,56
    +94,09 (+0,24%)
     

  • NASDAQ

    19.696,25
    +93,75 (+0,48%)
     

  • BATS 1000 Index

    0,0000
    0,0000 (0,00%)
     

  • EURO/R$

    5,7567
    -0,0024 (-0,04%)
     

Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks

David Wainer
·2 min de leitura
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks

Moderna, BioNTech, CureVac and Novavax have added billions of dollars in combined market capitalization gains in recent days after two cases of bird flu were reported in humans in the U.S. and reports emerged of a potential federal government vaccine program. On Wednesday, Moderna gained 14% while BioNTech added 11%. CureVac jumped 19%.

Continuar lendo